<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

Endoxifen hydrochloride

產(chǎn)品貨號

Axon 2707 CAS [1197194-41-4] MF C25H27NO2.HClMW 409.95 Purity: 99% Soluble in water and DMSO Description Metabolite of Tamoxifen and a selective estrogen receptor modulator (SERM); Potently inhibits the growth of estrogen-stimulated BT474 cells (IC50: 54 nM). Approximately 100-fold more potent as an antagonist of the ERα than the parent drug. Drug for the treatment of estrogen receptor (ER) positive breast cancer. Hydrochloride salt of Endoxifen (Axon 2190) which dissolves readily in water and aqueous media. KEYWORDS: Endoxifen hydrochloride | supplier | Endoxifen | SERM | CAS [1197194-41-4] | [110025-28-0] | Estrogen | Selective Estrogen Receptor (ER) Modulator | Nuclear receptor | metabolite | ER positive breast cancer | Tamoxifen

產(chǎn)品價格

現(xiàn)貨詢價，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

Endoxifen hydrochloride

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 2707

CAS [1197194-41-4]

MF C25H27NO2.HCl
MW 409.95

Purity: 99%
Soluble in water and DMSO

Endoxifen hydrochloride

Description

Metabolite of Tamoxifen and a selective estrogen receptor modulator (SERM); Potently inhibits the growth of estrogen-stimulated BT474 cells (IC50: 54 nM). Approximately 100-fold more potent as an antagonist of the ERα than the parent drug. Drug for the treatment of estrogen receptor (ER) positive breast cancer.
Hydrochloride salt of Endoxifen (Axon 2190) which dissolves readily in water and aqueous media.

J.R. Hawse et al. Endoxifen’s Molecular Mechanisms of Action Are Concentration Dependent and Different than That of Other Anti-Estrogens. PLoS One. 2013, 8, e54613.?

A Ahmad et al. Endoxifen, a New Cornerstone of Breast Cancer Therapy: Demonstration of Safety, Tolerability, and Systemic Bioavailability in Healthy Human Subjects. Clin. Pharmacol. Ther. 2010, 88(6), 814–817.?

M.D. Johnson et al. Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen. Breast Cancer Research and Treatment 2004, 85, 151-159.?

M. Goetz et al. Tamoxifen, HER2, and Endoxifen: The Role of CYP2D6 as a Predictor of Tamoxifen Resistance in ER+/HER2+ Breast Cancer. Cancer Res 2009, 69, Abstract nr 2006 (S3).?

Certificate of Analysis
Material Safety Data Sheet

Cell Signaling & Oncology Endocrinology Estrogen (ER) NR3A

Selective estrogen receptor modulator (SERM)

Chemical name

(E/Z)-4-(1-(4-(2-(Methylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol hydrochloride

Parent CAS No.

[110025-28-0]

產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>